Infectious_Disease

Infectious_Disease

Pandemic-related experiences of older adults and people with disabilities

PMCID: PMC12173368 PMID: 40526622 DOI: 10.1371/journal.pone.0325306 Journal: PloS one Publication Date: 2025-6-17 Authors: Mortenson WB, Esfandiari E, Mohammadi S, Sakakibara B, Schmidt J, et al. Key Points * COVID-19 restrictions dramatically altered capabilities and functionings for people with disabilities, creating unique challenges in daily life * 71 participants

Infectious_Disease

Infection Spread and Outbreaks Support with Spatial-Temporal Visualization Tool for Hospitals

PMCID: PMC12176923 PMID: 40531282 DOI: 10.1007/s10916-025-02219-7 Journal: Journal of medical systems Publication Date: 2025-6-18 Authors: Kim D, Canovas-Segura B, Campos M, Aleman Belando S, Juarez JM Key Points * Interactive visualization provides a novel method for tracking hospital-acquired infections across spatial and temporal dimensions * User evaluation showed 91.43%

Infectious_Disease

Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic’s cosmos database

PMCID: PMC12173228 PMID: 40526617 DOI: 10.1371/journal.pone.0326098 Journal: PloS one Publication Date: 2025-6-17 Authors: Nofzinger TB, Huang TT, Lingat CE, Amonkar GM, Edwards EE, et al. Key Points * Overall influenza vaccination rates decreased by 6.41 percentage points post-COVID-19 * Youngest age groups (5-18 and 19-26 years) experienced

Infectious_Disease

Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)

PMCID: PMC12174475 PMID: 40528677 DOI: 10.1111/irv.70131 Journal: Influenza and other respiratory viruses Publication Date: 2025-6-17 Authors: Baum U, Ikonen N, Luomala O, Poukka E, Leino T, et al. Key Points * COVID-19 containment measures effectively suppressed influenza transmission, creating a unique epidemiological "natural experiment" * Vaccine effectiveness

Infectious_Disease

Enhanced Surveillance of Sexually Transmitted Infections to Foster a Learning Public Health System

PMCID: PMC12175029 PMID: 40526386 DOI: 10.1001/jamanetworkopen.2025.14308 Journal: JAMA network open Publication Date: 2025-6-17 Authors: Reyes Nieva H, Zucker J, Tucker E, Castor D, Yin MT, et al. Key Points * Demonstrated potential of health information exchanges to enhance regional disease surveillance by integrating diverse data sources * Identified

Infectious_Disease

Clade II Mpox Infections Among Cruise Ship Passengers and Crew Members — United States, 2024

PMCID: PMC12176104 PMID: 40531694 DOI: 10.15585/mmwr.mm7422a1 Journal: MMWR. Morbidity and mortality weekly report Publication Date: 2025-6-19 Authors: Ortiz N, Rodriguez LR, McPherson M, Pringle K, Rao AK, et al. Key Points * Eight mpox cases identified across four cruise ship voyages, with transmission primarily among crew members and

Infectious_Disease

Animal movement estimation and network-based epidemic modeling: Illustration for the swine industry in Iowa (US)

PMCID: PMC12176235 PMID: 40531924 DOI: 10.1371/journal.pone.0326234 Journal: PloS one Publication Date: 2025-6-18 Authors: Yang Q, Martínez-López B, Moon SA, Gomez-Vazquez JP, Scoglio C Key Points * Synthetic network modeling reveals heterogeneous disease transmission risks across different farm types * Targeted infections at high out-degree farms could potentially cause

Infectious_Disease

Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

PMCID: PMC12176103 PMID: 40531798 DOI: 10.15585/mmwr.mm7422a3 Journal: MMWR. Morbidity and mortality weekly report Publication Date: 2025-6-19 Authors: Rao AK, Minhaj FS, Carter RJ, Duffy J, Satheshkumar PS, et al. Key Points * JYNNEOS is safe and recommended for diverse populations, including those with atopic dermatitis, immunocompromising conditions, and